MedPath

To assess role of Medicated enema through rectal and vaginal route in Anovulatio

Phase 3
Conditions
Health Condition 1: N970- Female infertility associated withanovulation
Registration Number
CTRI/2022/09/045244
Lead Sponsor
Dr Rupali Purohit
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Patients having active married life (minimum 1 year)

2. Patients with at least 2 or more consecutive anovulatory cycles in serial Trans Vaginal Sonography.

3. Patients with Primary or secondary both types of infertility.

4. Patients having anovulatory cycle with or without PCOD.

5. Patients who will be ready for consent, necessary investigations and regular follow up.

Exclusion Criteria

1. Patients suffering from the disorders of the reproductive tract such as tuberculosis, carcinoma, and congenital deformity of reproductive tract.

2. Patients suffering from Systemic diseases like Tuberculosis, Uncontrolled Hypertension and Diabetes Mellitus, Cardiac Disease, Thyroid disease and Hyperprolactinemia, STDs, HIV, HBsAg.

3. Patient suffering from fibroids, endometriosis, adenomyosis.

4. Infertility associated with other factors like tubal blockage, uterine factors, cervical factors etc.

5. Menorrhagia, Metrorrhagia, Dysfunctional Uterine Bleeding (DUB)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Ovulation occurs, formation of corpus luteumTimepoint: From 9th day to 22nd day depending on the ovulation every month for consecutive 3 months
Secondary Outcome Measures
NameTimeMethod
conceivedTimepoint: 3 months
© Copyright 2025. All Rights Reserved by MedPath